Mereo BioPharma (MREO) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts MREO Hot Sheet
Join SI Premium – FREE
Mereo BioPharma (NASDAQ: MREO) reported Q1 EPS of ($0.01), in-line with the analyst estimate of ($0.01).
For earnings history and earnings-related data on Mereo BioPharma (MREO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GameStop CEO Cohen buys 1.15M shares
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Brookfield prices $600M senior notes at 5.65% due 2031
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
